Tiniakou et al. followed 104 patients with anti-HMGCR myopathy across different age groups at the Johns Hopkins Myositis Center and found that statin exposure occurred in 40% of patients aged 52 years or younger, compared to 89–97% of those older than 52 years. Here, HMGCR is linked to myopathy.